Publicaciones científicas

Glucose metabolism during fasting is altered in experimental porphobilinogen deaminase deficiency

Collantes M (1), Serrano-Mendioroz I (2), Benito M (3), Molinet-Dronda F (4), Delgado M (5), Vinaixa M (6), Sampedro A (2), Enríquez de Salamanca R (7), Prieto E (8), Pozo MA (5), Peñuelas I (1), Corrales FJ (9), Barajas M (10), Fontanellas A (11).
(1) MicroPET Research Unit, CIMA-CUN, University of Navarra, Pamplona, Spain, Nuclear Medicine Department, Clínica Universidad de Navarra, Pamplona, Spain, Instituto de Investigación Sanitaria de Navarra (idiSNA), Pamplona, Spain.
(2) Hepatology Area, Centre for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.
(3) Medicina y Cirugía Experimental, Hospital General Universitario Gregorio Marañón, CIBERSAM, Madrid, Spain.
(4) MicroPET Research Unit, CIMA-CUN, University of Navarra, Pamplona, Spain, Movement Disorders Lab, Neuroscience Area, Centre for Applied Medical Research (CIMA), University of Navarra, Navarra, Spain.
(5) Unidad de Cartografía Cerebral, Instituto Pluridisciplinar, Universidad Complutense, Madrid, Spain.
(6) CIBERDEM-IISSPV-Centre for Omic Sciences (COS), Universitat Rovira i Virgili, Avinguda Universitat 3, Reus 43204, Spain.
(7) Research Center, Hospital Universitario 12 de Octubre, Universidad Complutense, Madrid, Spain.
(8) Nuclear Medicine Department, Clínica Universidad de Navarra, Pamplona, Spain, Instituto de Investigación Sanitaria de Navarra (idiSNA), Pamplona, Spain.
(9) Instituto de Investigación Sanitaria de Navarra (idiSNA), Pamplona, Spain, Hepatology Area, Centre for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain, Proteomics and Bioinformatics Laboratory, CIMA, University of Navarra, PRB2-ProteoRed-ISCIII, Pamplona, Spain, CIBERehd, University Clinic Navarra, Instituto de Salud Carlos III, Pamplona, Spain and.
(10) Health Science Department, Public University of Navarra (UPNA), Pamplona, Spain.
(11) Instituto de Investigación Sanitaria de Navarra (idiSNA), Pamplona, Spain, Hepatology Area, Centre for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain, CIBERehd, University Clinic Navarra, Instituto de Salud Carlos III, Pamplona, Spain

Revista: Human Molecular Genetics

Fecha: 21/01/2016

Radiofísica Medicina Nuclear

RESUMEN

Porphobilinogen deaminase (PBGD) haploinsufficiency (acute intermittent porphyria, AIP) is characterized by neurovisceral attacks when hepatic heme synthesis is activated by endogenous or environmental factors including fasting.

While the molecular mechanisms underlying the nutritional regulation of hepatic heme synthesis have been described, glucose homeostasis during fasting is poorly understood in porphyria. Our study aimed to analyse glucose homeostasis and hepatic carbohydrate metabolism during fasting in PBGD-deficient mice.

To determine the contribution of hepatic PBGD deficiency to carbohydrate metabolism, AIP mice injected with a PBGD-liver gene delivery vector were included. After a 14 h fasting period, serum and liver metabolomics analyses showed that wild-type mice stimulated hepatic glycogen degradation to maintain glucose homeostasis while AIP livers activated gluconeogenesis and ketogenesis due to their inability to use stored glycogen.

The serum of fasted AIP mice showed increased concentrations of insulin and reduced glucagon levels. Specific over-expression of the PBGD protein in the liver tended to normalize circulating insulin and glucagon levels, stimulated hepatic glycogen catabolism and blocked ketone body production. Reduced glucose uptake was observed in the primary somatosensorial brain cortex of fasted AIP mice, which could be reversed by PBGD-liver gene delivery.

In conclusion, AIP mice showed a different response to fasting as measured by altered carbohydrate metabolism in the liver and modified glucose consumption in the brain cortex. Glucose homeostasis in fasted AIP mice was efficiently normalized after restoration of PBGD gene expression in the liver.

CITA DEL ARTÍCULO  Hum Mol Genet. 2016 Jan 21. pii: ddw013.

tal vezLE INTERESE

¿QUÉ TECNOLOGÍA UTILIZAMOS?

La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

NUESTROS
PROFESIONALES

Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.

Imagen profesionales de la Clínica Universidad de Navarra

POR QUÉ VENIR
A LA CLÍNICA

Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.

Imagen del edificio de la Clínica Universidad de Navarra